As trombofilias na perda gestacional de repetição: uma revisão de prevalência e condutas
Objective: To discuss the role of thrombophilias in recurrent pregnancy loss, focusing on th e prevalence/association of these pathologies with recurrent abortion and treatment, through results of clinical trials, systematic reviews and meta-analyses. Methods: This is a non-systematic review of arti...
| Autores: | , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2023 |
| País: | Brasil |
| Institución: | Universidade Federal de Minas Gerais (UFMG) |
| Repositorio: | Repositório Institucional da UFMG |
| Idioma: | portugués |
| OAI Identifier: | oai:repositorio.ufmg.br:1843/77139 |
| Acceso en línea: | http://hdl.handle.net/1843/77139 |
| Access Level: | acceso abierto |
| Palabra clave: | Gravidez Aborto espontâneo Trombofilia Aborto Espontâneo |
| Sumario: | Objective: To discuss the role of thrombophilias in recurrent pregnancy loss, focusing on th e prevalence/association of these pathologies with recurrent abortion and treatment, through results of clinical trials, systematic reviews and meta-analyses. Methods: This is a non-systematic review of articles published in electronic databases PubMed, Cochrane, SciELO in the last five years, using the following descriptors: “recurrent pregnancy loss”, “recurrent abortion”, “habitual abortion”, “thrombophilia”, “antiphospholipid syndrome”, and “treatment”. Results: Most studies have reported a strong association between specific antiphospholipid antibodies and antiphospholipid antibody syndrome with recurrent pregnancy loss. Women carrying the factor V Leiden mutation, prothrombin gene mutation, and protein S deficiency were shown to be at high risk of recurrent pregnancy loss in a large systematic review. Recent studies have shown prevalence rates of hereditary thrombophilias and antiphospholipid antibody syndrome, in women with recurrent pregnancy loss, similar to those of the general population. Current studies endorse the use of heparin plus aspirin in women with antiphospholipid antibody syndrome, with an increase in live birth rate, but with no difference in obstetric complications. Conclusion: Although new studies demonstrate that the prevalence of hereditary and acquired thrombophilias in women with recurrent pregnancy loss is similar to that of the general population, routine investigation of antiphospholipid antibody syndrome in these patients is recommended. The use of low-dose aspirin plus heparin is the first-line pharmacological intervention for the prevention of recurrent pregnancy loss in patients with antiphospholipid antibody syndrome |
|---|